Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G, Mussetti A, Albasanz-Puig A, Salvador I, Sureda A, Gudiol C, Salazar R, Marin M, Garcia M, Navarro V, de la Haba Vaca I, Coma E, Sanz-Linares G, Dura X, Fontanals S, Serrano G, Cruz C, Mañez R. Moreno-González G, et al. Among authors: fontanals s. Trials. 2021 Feb 5;22(1):116. doi: 10.1186/s13063-021-05072-4. Trials. 2021. PMID: 33546739 Free PMC article.
Pharmaceutical care in the screening process of phase I oncohaematological clinical trials.
Rodríguez-Mauriz R, González-Laguna M, Perayre-Badia M, Lozano-Andreu T, Miquel-Zurita ME, Cañizares-Paz S, Santulario-Verdú L, Millan-Coll M, Fontanals S, Clopés-Estela A. Rodríguez-Mauriz R, et al. Among authors: fontanals s. Eur J Hosp Pharm. 2024 Dec 30:ejhpharm-2024-004168. doi: 10.1136/ejhpharm-2024-004168. Online ahead of print. Eur J Hosp Pharm. 2024. PMID: 39137972
Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib.
Marcé S, Xicoy B, García O, Cabezón M, Estrada N, Vélez P, Boqué C, Sagüés M, Angona A, Teruel-Montoya R, Ferrer-Marín F, Amat P, Hernández-Boluda JC, Ibarra MM, Anguita E, Cortés M, Fernández-Ruiz A, Fontanals S, Zamora L, On Behalf Of The Grupo Español de Leucemia Mieloide Crónica Gelmc. Marcé S, et al. Among authors: fontanals s. J Clin Med. 2021 Jul 16;10(14):3146. doi: 10.3390/jcm10143146. J Clin Med. 2021. PMID: 34300312 Free PMC article.
Everolimus Through Plasmatic Concentrations in Cancer Patients: Prospective Longitudinal Observational Multicentric Study (DIANA-1 Project).
Fort-Casamartina E, Pernas S, Otero S, Mate P, Gonzalo N, Narváez S, Rigo-Bonnin R, Padró-Miquel A, Teulé À, Garcia Del Muro X, Peiró I, Arribas L, Esteve A, Gonzalez A, Rey M, Clopés A, Fontanals S, Muñoz C. Fort-Casamartina E, et al. Among authors: fontanals s. J Clin Med. 2024 Dec 30;14(1):145. doi: 10.3390/jcm14010145. J Clin Med. 2024. PMID: 39797229 Free PMC article.
[Low dose of cyclophosphamide related to myocardiopathy].
Fontanals S, Cañete C, Soy D, Castro P, Nicolás JM. Fontanals S, et al. Farm Hosp. 2007 Nov-Dec;31(6):379-80. doi: 10.1016/s1130-6343(07)75410-7. Farm Hosp. 2007. PMID: 18348669 Spanish. No abstract available.